250 related articles for article (PubMed ID: 31766000)
21. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
[TBL] [Abstract][Full Text] [Related]
22. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
23. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
24. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Tillema JM; Hulst HE; Rocca MA; Vrenken H; Steenwijk MD; Damjanovic D; Enzinger C; Ropele S; Tedeschi G; Gallo A; Ciccarelli O; Rovira A; Montalban X; de Stefano N; Stromillo ML; Filippi M; Barkhof F;
Mult Scler; 2016 Jun; 22(7):901-9. PubMed ID: 26432859
[TBL] [Abstract][Full Text] [Related]
25. Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?
Andravizou A; Siokas V; Artemiadis A; Bakirtzis C; Aloizou AM; Grigoriadis N; Kosmidis MH; Nasios G; Messinis L; Hadjigeorgiou G; Dardiotis E; Peristeri E
Neurol Res; 2020 Jul; 42(7):575-586. PubMed ID: 32427076
[TBL] [Abstract][Full Text] [Related]
26. Transient impairment of olfactory threshold in acute multiple sclerosis relapse.
Bsteh G; Hegen H; Ladstätter F; Berek K; Amprosi M; Wurth S; Auer M; Di Pauli F; Deisenhammer F; Lutterotti A; Berger T
Mult Scler Relat Disord; 2018 Jul; 23():74-77. PubMed ID: 29783156
[TBL] [Abstract][Full Text] [Related]
27. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
[TBL] [Abstract][Full Text] [Related]
28. Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.
Bsteh G; Steiger R; Tuovinen N; Hegen H; Berek K; Wurth S; Auer M; Di Pauli F; Gizewski ER; Deisenhammer F; Berger T; Scherfler C
Mult Scler; 2020 May; 26(6):706-715. PubMed ID: 30895860
[TBL] [Abstract][Full Text] [Related]
29. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
Hegedüs K; Kárpáti J; Iljicsov A; Simó M
Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
[TBL] [Abstract][Full Text] [Related]
30. Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.
Rojas JI; Murphy G; Sanchez F; Patrucco L; Fernandez MC; Miguez J; Funes J; Golimstok A; Cristiano E
Neuroradiol J; 2018 Aug; 31(4):350-355. PubMed ID: 29869576
[TBL] [Abstract][Full Text] [Related]
31. Effect of deep gray matter atrophy on information processing speed in early relapsing-remitting multiple sclerosis.
Naghavi S; Ashtari F; Adibi I; Shaygannejad V; Ramezani N; Pourmohammadi A; Davanian F; Karimi Z; Khaligh-Razavi SM; Sanayei M
Mult Scler Relat Disord; 2023 Mar; 71():104560. PubMed ID: 36806043
[TBL] [Abstract][Full Text] [Related]
32. Inclusion of the Symbol Digit Modalities Test in a revised assessment of 'no evidence of disease activity-4 (NEDA-4)' in Latin-American patients with multiple sclerosis.
Guevara C; Villa E; Diaz V; Garrido C; Martinez M; Orellana P; Alarcón P; Silva-Rosas C; Barker GJ; Kempton MJ; de Grazia J
Mult Scler Relat Disord; 2020 Jul; 42():102076. PubMed ID: 32361478
[TBL] [Abstract][Full Text] [Related]
33. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
D'Ambrosio A; Pagani E; Riccitelli GC; Colombo B; Rodegher M; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2017 Aug; 23(9):1194-1203. PubMed ID: 27760859
[TBL] [Abstract][Full Text] [Related]
34. Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis.
Lazzarotto A; Margoni M; Franciotta S; Zywicki S; Riccardi A; Poggiali D; Anglani M; Gallo P
Cerebellum; 2020 Apr; 19(2):192-200. PubMed ID: 31898280
[TBL] [Abstract][Full Text] [Related]
35. Olfactory function combined with morphology distinguishes Parkinson's disease.
Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y
Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741
[TBL] [Abstract][Full Text] [Related]
36. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
[TBL] [Abstract][Full Text] [Related]
37. Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
Nelson F; Akhtar MA; Zúñiga E; Perez CA; Hasan KM; Wilken J; Wolinsky JS; Narayana PA; Steinberg JL
Mult Scler; 2017 May; 23(6):836-847. PubMed ID: 27613119
[TBL] [Abstract][Full Text] [Related]
38. Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration.
Bsteh G; Berek K; Hegen H; Teuchner B; Auer M; Wurth S; Di Pauli F; Deisenhammer F; Berger T
Mult Scler; 2020 Jan; 26(1):57-68. PubMed ID: 30465490
[TBL] [Abstract][Full Text] [Related]
39. Altered functional adaptation to attention and working memory tasks with increasing complexity in relapsing-remitting multiple sclerosis patients.
Amann M; Dössegger LS; Penner IK; Hirsch JG; Raselli C; Calabrese P; Weier K; Radü EW; Kappos L; Gass A
Hum Brain Mapp; 2011 Oct; 32(10):1704-19. PubMed ID: 21077147
[TBL] [Abstract][Full Text] [Related]
40. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]